BUSINESS
Haewon Biotech expands the scope of exploration and development of new biomaterials.
The oceans account for 71% of the earth's surface, but 95% of the space remains unknown. The potential for the development of the oceans is so vast that it is impossible to estimate. In the new biomaterials industry, medical biomaterials are being researched utilizing materials derived from marine life. For instance, collagen isolated from echinoderms can be used to make artificial blood vessels and artificial organs, and chitosan extracted from crustaceans can be utilized as artificial skin and biofilms. In particular, sulfur-containing polysaccharides extracted from brown algae can be used as substitute materials for heparin (extracted from pig organs), which are currently used for thrombolysis. Alginates derived from algae are already being used in the medical field.
Bio-new materials are one of the fields of wide application as new materials in textiles, plastic substitutes, dyes, medical, and other industries.
Haewon Biotech is striving to materialize bio-based materials derived from marine organisms step-by-step based on accumulated technology capability.